Top MostOvervalued Medical - Pharmaceuticals industry Stocks 2026

Cullinan Therapeutics, (CGEM) is the most overvalued stock in the Medical - Pharmaceuticals industry with an estimated 91.8% downside, followed by Atai Life Sciences (ATAI) at 75.1% and Insmed (INSM) at 56.7%.

Updated todayBased on intrinsic value modelsIndustry: Medical - Pharmaceuticals

Page snapshot: 27 July 2026, 2:12 am

View full analysis in the screener → · All most overvalued stocks →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Medical - Pharmaceuticals Industry Valuation Insights (Updated Today)

  • The Medical - Pharmaceuticals industry currently shows an average upside of 74.5% on this snapshot.
  • Top name Cullinan Therapeutics, Inc. (CGEM) trades at roughly a 91.8% discount to modeled intrinsic value—rankings move with prices and inputs.
  • This industry's average upside is below our broad mostOvervalued benchmark (~94.9%).

MostOvervalued Medical - Pharmaceuticals Stocks by Market Cap

Large cap (top 5)

  1. 1.Insmed Incorporated · INSM56.7%$23.18B

Mid cap (top 5)

  1. 1.Atai Life Sciences N.V. · ATAI75.1%$2.66B

Small cap (top 5)

  1. 1.Cullinan Therapeutics, Inc. · CGEM91.8%$1.05B

What Are the Most Overvalued Medical - Pharmaceuticals Stocks?

Most overvalued medical - pharmaceuticals stocks are names where price sits furthest above modeled fair (intrinsic) value—often expressed as the largest headline downside versus price.

This is not a sell list. Validate each symbol on its company page before you act.

How We Identify the Most Overvalued Medical - Pharmaceuticals Stocks

We pull an industry-filtered most-overvalued snapshot (price, intrinsic value, downside, cap, sector, country) and rank by headline downside. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about the most overvalued medical - pharmaceuticals names, intrinsic value, and how often this list refreshes.

What are mostOvervalued medical - pharmaceuticals stocks?

They are Medical - Pharmaceuticals names trading above modeled intrinsic value—shown here as downside % versus price. Models vary; use this as a screen, not advice.

How do you find mostOvervalued medical - pharmaceuticals stocks?

We load mostOvervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are medical - pharmaceuticals stocks mostOvervalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Are mostOvervalued medical - pharmaceuticals stocks a good investment?

Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.

Data updated regularly. Intrinsic value estimates and stock prices are subject to market fluctuations.